130 related articles for article (PubMed ID: 1600337)
21. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.
Celik I; Akalin S; Erbaş T
Eur J Endocrinol; 1995 Jun; 132(6):668-72. PubMed ID: 7788003
[TBL] [Abstract][Full Text] [Related]
23. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
[TBL] [Abstract][Full Text] [Related]
24. [Migration inhibition test with thyroid membrane antigen in Graves-Basedow disease and nodular goiter].
Jarzab J; Bachowska E; Jarzab B; Skrzypek J; Waler J
Endokrynol Pol; 1991; 42(3):397-405. PubMed ID: 1364488
[TBL] [Abstract][Full Text] [Related]
25. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis.
Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R
J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425
[TBL] [Abstract][Full Text] [Related]
26. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review.
van Dijk MM; Smits IH; Fliers E; Bisschop PH
Thyroid; 2018 Feb; 28(2):257-264. PubMed ID: 29325496
[TBL] [Abstract][Full Text] [Related]
27. Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
Shechner C; Kraiem Z; Zuckerman E; Dickstein G
Thyroid; 1992; 2(2):133-5. PubMed ID: 1356055
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of triiodothyronine thyrotoxicosis].
Semenov VD
Probl Endokrinol (Mosk); 1982; 28(6):32-5. PubMed ID: 6818538
[TBL] [Abstract][Full Text] [Related]
29. Thyrotoxicosis factitia masquerading as recurrent Graves' disease: endogenous antibody immunoassay interference, a pitfall for the unwary.
Jahagirdar VR; Strouhal P; Holder G; Gama R; Singh BM
Ann Clin Biochem; 2008 May; 45(Pt 3):325-7. PubMed ID: 18482926
[TBL] [Abstract][Full Text] [Related]
30. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
31. [Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months].
Yoshida K
Rinsho Byori; 2007 Jun; 55(6):560-5. PubMed ID: 17657991
[TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptor in sera of patients with Graves' disease.
Balazs C; Farid NR
J Autoimmun; 1991 Aug; 4(4):681-8. PubMed ID: 1777014
[TBL] [Abstract][Full Text] [Related]
33. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
Wenisch C; Myskiw D; Gessl A; Graninger W
J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
[TBL] [Abstract][Full Text] [Related]
34. [Thyroid stimulating antibodies in pregnant women with Graves' disease and neonatal thyrotoxicosis].
Nygaard B; Petersen JR; Jespersen NF
Ugeskr Laeger; 1997 Feb; 159(8):1086-9. PubMed ID: 9072852
[TBL] [Abstract][Full Text] [Related]
35. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
36. Congenital thyrotoxicosis in premature infants.
Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
[TBL] [Abstract][Full Text] [Related]
37. [Goiter size and prognosis of thyrotoxicosis treated medically].
Laurberg P; Hansen PE; Iversen E; Jensen SE; Weeke J
Ugeskr Laeger; 1987 May; 149(20):1325-7. PubMed ID: 3603777
[No Abstract] [Full Text] [Related]
38. Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves' disease and transient thyrotoxicosis.
Sayama N; Yoshida K; Mori K; Fukazawa H; Hori H; Nakazato N; Tani J; Nakagawa Y; Ito S
Endocr J; 1998 Dec; 45(6):767-72. PubMed ID: 10395232
[TBL] [Abstract][Full Text] [Related]
39. [TSH-receptor antibodies in thyroid diseases].
Hasse-Lazar K; Jarzab B; Podwiński A; Waler J; Sprzaczkowska K; Buła G; Skrzypek J
Pol Arch Med Wewn; 1997 Mar; 97(3):239-51. PubMed ID: 9333770
[TBL] [Abstract][Full Text] [Related]
40. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
